The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) Observational Follow‐Up Study: Benefits of RAS Blockade With Olmesartan Treatment Are Sustained After Study Discontinuation
2014 · Journal of the American Heart Association · 45 citations
https://doi.org/10.1161/jaha.114.000810